Optimizing Lymphedema Management After Breast Cancer: Predictive Risk Models in Clinical Practice
- PMID: 40358369
- PMCID: PMC12232080
- DOI: 10.1002/jso.28146
Optimizing Lymphedema Management After Breast Cancer: Predictive Risk Models in Clinical Practice
Abstract
Background and objectives: Lymphedema secondary to multimodal breast cancer treatment is a relatively common complication that significantly impacts patients' quality of life. Despite identifying several associated risk factors, accurately assessing individual risk remains challenging. This study aims to develop predictive tools integrating patient characteristics, tumor attributes, and treatment modalities to optimize clinical surveillance, enhance prevention, and enable earlier diagnosis.
Methods: Data were analyzed from 309 patients referred to the Lymphedema Unit of Rehabilitation Service who underwent lymphadenectomy for breast cancer between January 2016 and December 2021. Collected variables included patient demographics, tumor clinicopathological features, and treatment details. A lymphedema incidence study was conducted, complemented by univariate and multivariate regression analyses to identify risk factors. A nomogram was developed to predict high-risk patients, facilitating personalized prevention and management strategies.
Results: The cumulative incidence of lymphedema was 18.4%. Independent risk factors included high body mass index, sedentary lifestyle, number of positive nodes (N stage), and radiotherapy, particularly targeting the breast, axilla, and supra-infraclavicular regions. The logistic regression model demonstrated an area under the ROC curve (AUC) of 0.75, with acceptable calibration, validating the predictive model.
Conclusions: The predictive tools developed provide healthcare professionals with a means to identify patients at elevated risk of lymphedema, supporting individualized prevention and management.
Keywords: breast cancer; lymphadenectomy; lymphedema; predictive tools; risk factors.
© 2025 The Author(s). Journal of Surgical Oncology published by Wiley Periodicals LLC.
Figures
Similar articles
-
Development and validation of a predictive nomogram for postoperative upper limb lymphedema in breast cancer patients: a retrospective cohort study.Sci Rep. 2025 Jul 9;15(1):24609. doi: 10.1038/s41598-025-10461-9. Sci Rep. 2025. PMID: 40634491 Free PMC article.
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Lymphadenectomy or sentinel node biopsy for the management of endometrial cancer.Cochrane Database Syst Rev. 2025 Jun 10;6(6):CD015786. doi: 10.1002/14651858.CD015786.pub2. Cochrane Database Syst Rev. 2025. PMID: 40492478 Review.
-
The LyBra score: A risk assessment tool to address targeted prevention against breast cancer - Related lymphedema.Eur J Surg Oncol. 2025 Jul;51(7):109754. doi: 10.1016/j.ejso.2025.109754. Epub 2025 Mar 7. Eur J Surg Oncol. 2025. PMID: 40101680
-
Axillary treatment for operable primary breast cancer.Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD004561. doi: 10.1002/14651858.CD004561.pub3. Cochrane Database Syst Rev. 2017. PMID: 28052186 Free PMC article.
References
-
- Ferlay J., EM Lam F., Laversanne M., et al., “Global Cancer Observatory: Cancer Today,” 2022, https://gco.iarc.who.int/today.
-
- Arroyo‐Yustos M., Martín Angulo M., and Álvarez‐Mon soto M., “Cáncer De Mama,” Medicine‐Programa de Formación Médica Continuada Acreditado 12, no. 34 (2017): 2011–2023.
-
- “Cancer Stat Facts: Female Breast Cancer [Internet],” National Cancer Institute, 2014, https://seer.cancer.gov/statfacts/html/breast.html.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical